- 日
- 関
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/04/16 20:49:27」(JST)
[Wiki en表示]
Enviomycin
|
Systematic (IUPAC) name |
3,6-diamino-N-[(3R,6Z)-3-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Pregnancy cat. |
? |
Legal status |
℞ Prescription only |
Routes |
IM |
Identifiers |
CAS number |
33103-22-9 |
ATC code |
None |
PubChem |
CID 3032903 |
ChemSpider |
16736480 |
UNII |
XU299C23A2 Y |
KEGG |
D07897 Y |
Chemical data |
Formula |
C25H43N13O10 |
Mol. mass |
685.69 g/mol |
SMILES
- C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CO)CO)NC
|
InChI
-
InChI=1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/b13-7-/t10-,11-,12+,14+,15+,16-,18+/m1/s1
Key:HPWIIERXAFODPP-GHBBWTPBSA-N
|
Y (what is this?) (verify)
|
Enviomycin (INN, also called tuberactinomycin N) is an antibiotic drug, isolated from Streptomyces griseoverticillatus var. tuberacticus.[1] It is used in the treatment of tuberculosis.[2]
References
- ^ Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732
- ^ Selvakumar, N; Kumar, V; Acharyulu, GS; Rehman, F; Paramasivan, CN; Prabhakar, R (1992). "Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin". The Indian journal of medical research 95: 101–4. PMID 1506058.
English Journal
- Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.
- Akbergenov R1, Shcherbakov D, Matt T, Duscha S, Meyer M, Wilson DN, Böttger EC.
- Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2011 Oct;55(10):4712-7. doi: 10.1128/AAC.00628-11. Epub 2011 Jul 18.
- Capreomycin and the structurally similar compound viomycin are cyclic peptide antibiotics which are particularly active against Mycobacterium tuberculosis, including multidrug resistant strains. Both antibiotics bind across the ribosomal interface involving 23S rRNA helix 69 (H69) and 16S rRNA helix
- PMID 21768509
- When do adaptive plasticity and genetic evolution prevent extinction of a density-regulated population?
- Chevin LM1, Lande R.
- Evolution; international journal of organic evolution.Evolution.2010 Apr 1;64(4):1143-50. doi: 10.1111/j.1558-5646.2009.00875.x. Epub 2009 Oct 23.
- We study the dynamics of evolutionary recovery after an abrupt environmental shift in a density-regulated population with evolving plasticity. Maladaptation to the new environment initially causes the population to decline, until adaptive phenotypic plasticity and genetic evolution restore positive
- PMID 19863583
- [Case of multi-drug resistant pulmonary tuberculosis with bilateral cavitary lesions successfully treated by surgical treatment].
- Okumura M1, Ogata H, Yoshiyama T, Kokutoh H, Tadokoro E, Kubota M, Ueyama M, Wada M, Nakajima Y.
- Kekkaku : [Tuberculosis].Kekkaku.2007 Nov;82(11):831-5.
- A case was 38 years old male. He was pointed out abnormal shadow on chest X-ray and complained respiratory infection symptoms. He had not past history of tuberculosis. He was diagnosed as multi-drug resistant tuberculosis (MDR-TB) in a certain hospital and was referred to our hospital to undergo tre
- PMID 18078108
Japanese Journal
- 外科療法が有効であった両側空洞, 初回重症多剤耐性肺結核症の1例
- 奥村 昌夫,尾形 英雄,吉山 崇,国東 博之,田所 衛司,窪田 素子,上山 雅子,和田 雅子,中島 由槻
- 結核 82(11), 831-835, 2007-11-15
- … His drug sensitivity test by Ogawa medium was resistant to all anti-tuberculosis drugs except for kanamycin (KM) and enviomycin (EVM). …
- NAID 10025687914
- 左荒蕪肺を呈した多剤耐性肺結核に左肺全摘術を施行した1例
- 小山 和彦,川上 健司,原田 義高,山領 豪,木村 由美子
- 結核 82(7), 577-581, 2007-07-15
- … As the drug susceptibility test revealed that the isolated strain was multi-drug resistant, the regimen was changed to pyrazinamide, ethionamide, cycloserine, enviomycin, and levofloxacin. …
- NAID 10019827586
- 漢方治療が奏効したと思われる肺 Mycobacterium fortuitum 感染症の1例
- 野上 達也,関矢 信康,三潴 忠道,山口 哲生
- 結核 81(8), 525-529, 2006-08-15
- … He had been suffering from these symptoms since 1982, though the intensive anti-mycobacterial chemotherapy such as three-drug (RFP, SM, &INH), twice two-drug (KM & SM and cycloserine & enviomycin) and four-drug (CAM, EB, RFP, & KM) regimens were administered for 26 months from July 1999. …
- NAID 10018335686
Related Links
- 日本における発売年. 1975(昭和50)年. 3. 特長. 抗酸菌に対して強い抗菌力を有する。 臨床試験における有効率は初回治療例で98.7%(78/79)、再治療例で39.1%(330/ 844)である。 総症例305例中、101例(33.11%)に副作用が認められた。(承認時) ...
- Enviomycin. From Wikipedia, the free encyclopedia. Jump to: navigation, search ... Enviomycin (INN, also called tuberactinomycin N) is an antibiotic drug, isolated from Streptomyces griseoverticillatus var. tuberacticus. It is used in the treatment ...
Related Pictures
★リンクテーブル★
[★]
- 英
- enviomycin
- 化
- 硫酸エンビオマイシン enviomycin sulfate EVM
- 商
- ツベラクチン
- 関
- 抗結核薬
[★]
- 関
- enviomycin